登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《LANCET，4月9日，Delayed access or provision of care in Italy resulting from fear of COVID-19》

  • 来源专题：COVID-19科研动态监测
  • 编译者： xuwenwhlib
  • 发布时间：2020-04-10

  • Delayed access or provision of care in Italy resulting from fear of COVID-19

    Marzia Lazzerini

    Egidio Barbi

    Andrea Apicella

    Federico Marchetti

    Fabio Cardinale

    Gianluca Trobia

    Published:April 09, 2020DOI:https://doi.org/10.1016/S2352-4642(20)30108-5

    During Italy's national lockdown for coronavirus disease 2019 (COVID-19), official hospital statistics in the period March 1–27, 2020, show substantial decreases—ranging from 73% to 88%—in paediatric emergency department visits compared with the same time period in 2019 and 2018 (figure). Similarly, family paediatricians widely report a considerable reduction in clinic visits, although this is difficult to measure precisely.

  • 原文来源：https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(20)30108-5/fulltext
78浏览量
原文链接
相关报告

  • 《LANCET，3月21日，COVID-19: protecting health-care workers》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-20
    • COVID-19: protecting health-care workers The Lancet Published:March 21, 2020DOI:https://doi.org/10.1016/S0140-6736(20)30644-9 Worldwide, as millions of people stay at home to minimise transmission of severe acute respiratory syndrome coronavirus 2, health-care workers prepare to do the exact opposite. They will go to clinics and hospitals, putting themselves at high risk from COVID-2019. Figures from China's National Health Commission show that more than 3300 health-care workers have been infected as of early March and, according to local media, by the end of February at least 22 had died. In Italy, 20% of responding health-care workers were infected, and some have died. Reports from medical staff describe physical and mental exhaustion, the torment of difficult triage decisions, and the pain of losing patients and colleagues, all in addition to the infection risk.
    140浏览量
    原文链接

  • 《LANCET，4月9日，Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-04-10
    • Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed Marc Feldmann，Ravinder N Maini，James N Woody，Stephen T Holgate，Gregory Winter Matthew Rowland Published:April 09, 2020DOI:https://doi.org/10.1016/S0140-6736(20)30858-8 With more than 81?000 deaths worldwide from coronavirus disease 2019 (COVID-19) by April 8, 2020,1 it is incumbent on researchers to accelerate clinical trials of any readily available and potentially acceptably safe therapies that could reduce the rising death toll. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) gains access to host cells via angiotensin-converting enzyme 2, which is expressed in the type II surfactant-secreting alveolar cells of the lungs.2 Severe COVID-19 is associated with a major immune inflammatory response with abundant neutrophils, lymphocytes, macrophages, and immune mediators. Which mediators are most important in driving the immune pathology remains to be elucidated. Deaths from COVID-19 are chiefly due to diffuse alveolar damage with pulmonary oedema, hyaline membrane formation, and interstitial mononuclear inflammatory infiltrate compatible with early-phase adult respiratory distress syndrome (ARDS).3 Prevention of ARDS and death in patients with COVID-19 is a pressing health emergency.
    4浏览量
    原文链接